ebselen has been researched along with mupirocin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Seleem, MN; Thangamani, S; Younis, W | 1 |
1 other study(ies) available for ebselen and mupirocin
Article | Year |
---|---|
Repurposing ebselen for treatment of multidrug-resistant staphylococcal infections.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Azoles; Bacterial Toxins; Biofilms; Cell Survival; Cells, Cultured; Daptomycin; Drug Repositioning; Drug Synergism; Female; Host-Pathogen Interactions; Humans; Isoindoles; Keratinocytes; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mupirocin; Organoselenium Compounds; Skin; Staphylococcal Infections | 2015 |